MRI Scan to Predict Liver Cancer Treatment Response
Part of Cancer, Digestive system clinical trials.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (HCC)
- You are scheduled for or have had TACE treatment (a procedure that delivers cancer-fighting drugs directly to the liver)
- You do not have significant lung or breathing disease
- You can lie still in an MRI machine for about 2 hours
- You do not have a pacemaker, metal implants, or other devices that MRI cannot scan
- You are not allergic to MRI contrast dye (the liquid used to make images clearer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
This trial tests if a shorter MRI scan can effectively monitor liver cancer after a procedure called TACE. If you've had TACE for liver cancer and have good liver function, you may be able to join.
This trial compares a shorter MRI using a special dye to a CT scan for detecting liver cancer recurrence in people who have been cancer-free for at least two years after surgery or local treatment.
This study looks at ways to improve screening for liver cancer in adults with long-term liver disease. It may help catch liver cancer earlier, which can make treatment easier.
This trial uses a special MRI scan (3D-MRE) to see how well liver cancer responds to conversion therapy, which aims to shrink tumors enough for surgery. It helps doctors understand if the treatment is working.
This study uses a special MRI machine to take detailed images of the liver. It includes people newly diagnosed with liver cancer who haven't had treatment yet, as well as healthy volunteers for comparison. The goal is to see how well the machine works for different patients.
Hear when a new TACE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.